Skip to main content

FDA recall, , Moderate risk

GORE VIABIL Short Wire Biliary Endoprosthesis

The GORE VIABIL biliary endoprosthesis may be mislabeled, with a 10 mm x 7 cm device labeled as a 10 mm x 10 cm device.

What happened

W L Gore & Associates, Inc. of Flagstaff, Arizona, recalled the GORE VIABIL Short Wire Biliary Endoprosthesis, Model Nos. VSWVN1010 and VSWVN1006, because 10 mm diameter x 7 cm devices with transmural drainage holes were incorrectly labeled as 10 mm diameter x 10 cm length devices without those holes. The recall began May 22, 2026, and was added to the FDA's Enforcement Report on August 7, 2026. The products were distributed in Georgia and Rhode Island.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

2 products

Affected if its UDI-DI is listed.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Gore Viabil Short Wire Biliary Endoprosthesis, Model No. VSWVN1010. Flexible, self-expanding endoprosthesis designed to maintain luminal patency of the common bile duct which may be obstructed.

    UDI-DI
    • 00733132638888
    • 30965053
    • 30965054
    • 30965055
    • 30965056
    • 30965057
    • 30965058
    • 30965059
    • 30965060
    • 30965061
    • 30965062
    • 30965063
    • 30965064
    • 30965065
  2. Gore Viabil Short Wire Biliary Endoprosthesis, Model No. VSWVN1006. Flexible, self-expanding endoprosthesis designed to maintain luminal patency of the common bile duct which may be obstructed.

    UDI-DI
    • 00733132638796
    • 30970948
    • 30970949
    • 30970950
    • 30970951
    • 30970952
    • 30970953
    • 30970954
    • 30970955
    • 30970956
    • 30970957
    • 30970958
    • 30970959
    • 30970960

Recall details

Company began the recall
Sold in

U.S. Nationwide distribution in the states of Georgia and Rhode Island.

Company
W L Gore & Associates, Inc.Flagstaff, Arizona
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99143
Recall numbers
Z-2914-2026 to Z-2915-2026

All recalls from W L Gore & Associates, Inc.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)